Assembly Biosciences (ASMB) Misses Q2 EPS by 133c

Assembly Biosciences (NASDAQ: ASMB) reported Q2 EPS of ($1.33). Revenue for the quarter came in at $9.62 million.

For earnings history and earnings-related data on Assembly Biosciences (ASMB) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• GMR Solutions to reprice $2.9B term loan, pay down $200M in debt